Healthcare Leaders Income Fund (HHL-T) Stock Predictions - Stockchase
WATCH LIST
25
Healthcare Leaders Income Fund (HHL-T)

ON STOCKCHASE SINCE Feb 2015

E.T.F.'s

Healthcare Leaders Income...

HHL-T

34 watching          
Join the Discussion

Healthcare Leaders Income Fund (HHL-T) SAVE Apr, 19, 2019, 9:06 am

7.27 0.03 (0.41%)

What the experts are saying about HHL-T



  • All
  • Filtered
Signal Opinion Expert
COMMENT
No cannabis in this. It's 20 equal-weighted healthcare stocks, the biggest in the world, the mega-caps. Lately this has underperformed the S&P so beware as we head into a rate-sensitive market. It's more risky than your typical ETF.
E.T.F.'s
0 0 0 0 0
0 comments
No cannabis in this. It's 20 equal-weighted healthcare stocks, the biggest in the world, the mega-caps. Lately this has underperformed the S&P so beware as we head into a rate-sensitive market. It's more risky than your typical ETF.
E.T.F.'s
0 0 0 0 0
0 comments
Mike Philbrick

President, ReSolve Asset Manage...

Price Price
$7.500
Owned Owned
Unknown

BUY
Caller looking for a defensive holding. He loves what they are doing – an active approach to healthcare. They write covered calls and can generate capital gains. It should perform well in a downturn. Once we are at a low valuation and they are recovering you don’t want to be in this.
E.T.F.'s
0 0 0 0 0
0 comments
Caller looking for a defensive holding. He loves what they are doing – an active approach to healthcare. They write covered calls and can generate capital gains. It should perform well in a downturn. Once we are at a low valuation and they are recovering you don’t want to be in this.
E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$7.880
Owned Owned
Unknown

COMMENT
Popular. It has a covered call overlay so it's one of the more pricey ETFs at a 1.37% MER. They do quantitative screens on the healthcare companies they pick.
E.T.F.'s
0 0 0 0 0
0 comments
Popular. It has a covered call overlay so it's one of the more pricey ETFs at a 1.37% MER. They do quantitative screens on the healthcare companies they pick.
E.T.F.'s
0 0 0 0 0
0 comments
Daniel Straus

Head of ET, National Bank Financ...

Price Price
$7.990
Owned Owned
Unknown

BUY
It is the healthcare leaders strategy ETF, actively managed with a covered call overlay. He sees a yield of about 9% but the holdings yield 3-4% so the rest is from the options strategy. The yield is sustainable if the managers know what they are doing. He likes the exposure and what they are trying to do.
E.T.F.'s
0 0 0 0 0
0 comments
It is the healthcare leaders strategy ETF, actively managed with a covered call overlay. He sees a yield of about 9% but the holdings yield 3-4% so the rest is from the options strategy. The yield is sustainable if the managers know what they are doing. He likes the exposure and what they are trying to do.
E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$7.820
Owned Owned
Unknown

DON'T BUY

Ignore this one. A recent arrival. Another covered call ETF. Compare it to ZUH or XLB, which are so much cheaper. If you like the healthcare sector, which he would question with the Trump wild card, be careful and pick a mainstream ETF.

E.T.F.'s
0 0 0 0 0
0 comments

Ignore this one. A recent arrival. Another covered call ETF. Compare it to ZUH or XLB, which are so much cheaper. If you like the healthcare sector, which he would question with the Trump wild card, be careful and pick a mainstream ETF.

E.T.F.'s
0 0 0 0 0
0 comments
Terry Shaunessy

President , Shaunessy Investment...

Price Price
$8.390
Owned Owned
No

DON'T BUY

Health care leaders.  They use option strategies to enhance yield.  As broad markets turned down in '15/16, this index fell and now that things have recovered, it has done so but less than the market.  This is a way to play this space.  It is an active strategy and a fine one if you want exposure to healthcare.

E.T.F.'s
0 0 0 0 0
0 comments

Health care leaders.  They use option strategies to enhance yield.  As broad markets turned down in '15/16, this index fell and now that things have recovered, it has done so but less than the market.  This is a way to play this space.  It is an active strategy and a fine one if you want exposure to healthcare.

E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$8.280
Owned Owned
No

BUY

It's been building a base and current levels may rise past $9. He likes this, though it's in a volatile sector. HHL is acting quite well. He'd buy it now, and certainly when it breaks out past $9.

E.T.F.'s
0 0 0 0 0
0 comments

It's been building a base and current levels may rise past $9. He likes this, though it's in a volatile sector. HHL is acting quite well. He'd buy it now, and certainly when it breaks out past $9.

E.T.F.'s
0 0 0 0 0
0 comments
Elliott Fishman

Director o, Trading Services Gro...

Price Price
$8.160
Owned Owned
Unknown

COMMENT

HHL-T vs ZUB: The performance of HHL has been mediocre since 2015. You're buying yield, but not getting growth. But there's nothing wrong with great yield. In ZUB, you get the opposite. Growth vs. yield: Which do you want?

E.T.F.'s
0 0 0 0 0
0 comments

HHL-T vs ZUB: The performance of HHL has been mediocre since 2015. You're buying yield, but not getting growth. But there's nothing wrong with great yield. In ZUB, you get the opposite. Growth vs. yield: Which do you want?

E.T.F.'s
0 0 0 0 0
0 comments
John Hood

President , J. C Hood Investment...

Price Price
$8.060
Owned Owned
Unknown

HOLD

An aging population is good for this sector, but this sector is under scrutiny, too. Trump is getting tough on drug prices. That said, healthcare is a good place to be. He wouldn't add to an existing position. Hold no more than 5% in a sector.

E.T.F.'s
0 0 0 0 0
0 comments

An aging population is good for this sector, but this sector is under scrutiny, too. Trump is getting tough on drug prices. That said, healthcare is a good place to be. He wouldn't add to an existing position. Hold no more than 5% in a sector.

E.T.F.'s
0 0 0 0 0
0 comments
Richard Croft

President, R.N. Croft Financial...

Price Price
$8.080
Owned Owned
Unknown

BUY

Largely international healthcare companies with an option strategy overlaying it.  It is an active strategy.  It is a nice combination for exposure to the healthcare sector.  It will be a good yielder but not a big grower.

E.T.F.'s
0 0 0 0 0
0 comments

Largely international healthcare companies with an option strategy overlaying it.  It is an active strategy.  It is a nice combination for exposure to the healthcare sector.  It will be a good yielder but not a big grower.

E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$8.450
Owned Owned
Unknown

WEAK BUY

He loves covered call strategies.  They are very active managers and he thinks they do a very good job of it.  The last few years have been an up market in the healthcare market.  XLV-N is the broad US healthcare market.  You have a much better return with HHL-T because of the dividend as well.  It is a good way to hold healthcare late in the cycle.

E.T.F.'s
0 0 0 0 0
0 comments

He loves covered call strategies.  They are very active managers and he thinks they do a very good job of it.  The last few years have been an up market in the healthcare market.  XLV-N is the broad US healthcare market.  You have a much better return with HHL-T because of the dividend as well.  It is a good way to hold healthcare late in the cycle.

E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$8.300
Owned Owned
No

DON'T BUY

The US healthcare bill having failed Friday puts some risk into the sector.  He would be fine if it fell back to support levels, but would not step in today, otherwise it is a fine quality holding.

E.T.F.'s
0 0 0 0 0
0 comments

The US healthcare bill having failed Friday puts some risk into the sector.  He would be fine if it fell back to support levels, but would not step in today, otherwise it is a fine quality holding.

E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$8.400
Owned Owned
Unknown

COMMENT

This invests in healthcare related securities, and believes the enhancement comes from an option strategy overlay. Like any other sector, this is fine when it is going up. This ETF tends to have a lot of volatility compared to some of the others. He doesn’t use this, so doesn’t know that much about it. It’s a fine product and he has no issues with it. It has a pretty significant yield, which tends to be what attracts a lot of people. Dividend yield of 8%+ right now.

E.T.F.'s
0 0 0 0 0
0 comments

This invests in healthcare related securities, and believes the enhancement comes from an option strategy overlay. Like any other sector, this is fine when it is going up. This ETF tends to have a lot of volatility compared to some of the others. He doesn’t use this, so doesn’t know that much about it. It’s a fine product and he has no issues with it. It has a pretty significant yield, which tends to be what attracts a lot of people. Dividend yield of 8%+ right now.

E.T.F.'s
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$8.460
Owned Owned
No

COMMENT

This is his company’s fund. It hedges its currency and has 20 large cap global healthcare companies. One of the greatest risks in the market right now is individual stock risk.

E.T.F.'s
0 0 0 0 0
0 comments

This is his company’s fund. It hedges its currency and has 20 large cap global healthcare companies. One of the greatest risks in the market right now is individual stock risk.

E.T.F.'s
0 0 0 0 0
0 comments
Paul Macdonald

Chief Inve, Harvest Portfolios G...

Price Price
$8.290
Owned Owned
Yes

COMMENT

What is really going to drive outperformance is having some diversification, but over and above that, be able to overweight which sectors will outperform. A passive product is not going to do that for you. It makes sense to own an actively managed product.

E.T.F.'s
0 0 0 0 0
0 comments

What is really going to drive outperformance is having some diversification, but over and above that, be able to overweight which sectors will outperform. A passive product is not going to do that for you. It makes sense to own an actively managed product.

E.T.F.'s
0 0 0 0 0
0 comments
Dean Orrico

President, Middlefield Capital ...

Price Price
$7.930
Owned Owned
Unknown

Showing 1 to 15 of 25 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days